$SBRA
Sabra Health Care REIT, Inc. Stock $sbra

$sbra Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149229824000008 Filed on February 27, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$166.7M	$163.4M	$647.5M
YoY Change	3.36%	-0.96%	3.63%
Cost Of Revenue	$49.67M	$45.19M	$177.3M
YoY Change	13.82%	15.41%	24.0%
Gross Profit	$117.1M	$118.2M	$470.2M
YoY Change	-0.52%	-6.06%	-2.39%
Gross Profit Margin	70.21%	72.34%	72.62%
Selling, General & Admin	$11.75M	$16.32M	$47.66M
YoY Change	14.17%	48.29%	20.01%
% of Gross Profit	10.04%	13.81%	10.14%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$42.91M	$42.88M	$183.1M
YoY Change	-18.77%	-14.12%	-2.5%
% of Gross Profit	36.65%	36.27%	38.94%
Operating Expenses	$58.99M	$63.89M	$248.7M
YoY Change	-12.33%	-2.57%	0.63%
Operating Profit	$58.09M	$54.32M	$221.5M
YoY Change	15.26%	-9.85%	-5.58%
Interest Expense	-$29.00M	-$28.70M	-$115.9M
YoY Change	-1.28%	-75.3%	-43.07%
% of Operating Profit	-49.93%	-52.83%	-52.3%
Other Income/Expense, Net	$760.0K	$28.00K	-$75.57M
YoY Change	-103.35%	-114.29%	458.98%
Pretax Income	$27.30M	$17.65M	$18.66M
YoY Change	-444.68%	-120.81%	-13.91%
Income Tax	$453.0K	$493.0K	$2.002M
% Of Pretax Income	1.66%	2.79%	10.73%
Net Earnings	$26.25M	$17.16M	$13.76M
YoY Change	-376.74%	-120.2%	-117.73%
Net Earnings / Revenue	15.74%	10.5%	2.12%
Basic Earnings Per Share	$0.11		$0.06
Diluted Earnings Per Share	$0.11	$0.07	$0.06
COMMON SHARES
Basic Shares Outstanding	231.5M shares	231.2M shares	231.2M shares
Diluted Shares Outstanding	233.4M shares		232.8M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$59.93M	$41.29M	$41.29M
YoY Change	78.72%	-16.27%	-16.27%
Cash & Equivalents	$59.93M	$41.29M	$41.29M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$196.9M	$175.1M	$175.1M
YoY Change	18.44%	-11.22%	-11.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.589B	$4.617B	$4.617B
YoY Change	-4.34%	-6.9%	-6.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$132.0M	$136.8M	$194.7M
YoY Change	-5.29%	1.39%	4.65%
Other Assets	$6.003M	$5.434M	$5.434M
YoY Change	16.52%	17.52%	17.52%
Total Long-Term Assets	$5.178B	$5.211B	$5.211B
YoY Change	-3.94%	-6.11%	-6.11%
TOTAL ASSETS
Total Short-Term Assets	$196.9M	$175.1M	$175.1M
Total Long-Term Assets	$5.178B	$5.211B	$5.211B
Total Assets	$5.374B	$5.386B	$5.386B
YoY Change	-3.27%	-6.29%	-6.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$79.06M	$120.5M	$120.5M
YoY Change	-34.98%	-2.88%	-2.88%
Accrued Expenses	$33.70M	$16.50M	$16.50M
YoY Change	57.48%	-9.34%	-9.34%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$112.8M	$137.0M	$137.0M
YoY Change	-21.15%	-3.71%	-3.71%
LONG-TERM LIABILITIES
Long-Term Debt	$2.463B	$2.414B	$2.414B
YoY Change	2.79%	-3.7%	-3.7%
Other Long-Term Liabilities	$31.12M	$32.53M	$32.53M
YoY Change	-23.1%	-22.99%	-22.99%
Total Long-Term Liabilities	$2.495B	$2.447B	$2.447B
YoY Change	2.36%	-4.02%	-4.02%
TOTAL LIABILITIES
Total Short-Term Liabilities	$112.8M	$137.0M	$137.0M
Total Long-Term Liabilities	$2.495B	$2.447B	$2.447B
Total Liabilities	$2.607B	$2.584B	$2.584B
YoY Change	1.05%	-4.0%	-4.0%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$2.315M	$2.313M
YoY Change	0.13%	0.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.767B	$2.803B	$2.803B
YoY Change
Total Liabilities & Shareholders Equity	$5.374B	$5.386B	$5.386B
YoY Change	-3.27%	-6.29%	-6.29%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$26.25M	$17.16M	$13.76M
YoY Change	-376.74%	-120.2%	-117.73%
Depreciation, Depletion And Amortization	$42.91M	$42.88M	$183.1M
YoY Change	-18.77%	-14.12%	-2.5%
Cash From Operating Activities	$52.80M	$78.74M	$300.6M
YoY Change	-22.69%	16.5%	-4.8%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$38.90M	$78.53M
YoY Change	-100.0%	373.29%	-14.83%
Acquisitions
YoY Change
Other Investing Activities	-$13.22M	-$22.88M	$181.7M
YoY Change	-108.65%	-0.27%	-246.45%
Cash From Investing Activities	-$13.22M	-$61.78M	$103.1M
YoY Change	-111.68%	98.26%	-147.69%
FINANCING ACTIVITIES
Cash Dividend Paid	$69.44M		$277.4M
YoY Change	0.13%		0.1%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$20.23M	-9.363M	-$410.3M
YoY Change	-89.68%	-30.74%	153.73%
NET CHANGE
Cash From Operating Activities	$52.80M	78.74M	$300.6M
Cash From Investing Activities	-$13.22M	-61.78M	$103.1M
Cash From Financing Activities	-$20.23M	-9.363M	-$410.3M
Net Change In Cash	$19.34M	7.595M	-$6.599M
YoY Change	-232.42%	-66.85%	-89.39%
FREE CASH FLOW
Cash From Operating Activities	$52.80M	$78.74M	$300.6M
Capital Expenditures	$0.00	$38.90M	$78.53M
Free Cash Flow	$52.80M	$39.84M	$222.0M
YoY Change	84.22%	-32.9%	-0.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	17900000	usd
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Tustin
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92782
CY2023	dei	City Area Code CityAreaCode	888
CY2023	dei	Local Phone Number LocalPhoneNumber	393-8248
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	141000	usd
CY2021	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	9499000	usd
CY2023	sbra	Proceeds Payments From Issuance Of Stock Net Of Taxes Paid On Behalf Of Employees ProceedsPaymentsFromIssuanceOfStockNetOfTaxesPaidOnBehalfOfEmployees	-2682000	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	277447000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001492298
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2023#HealthCareResidentServiceMember
CY2021	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2023#HealthCareResidentServiceMember
CY2022	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2023#HealthCareResidentServiceMember
CY2023	us-gaap	Gain On Business Interruption Insurance Recovery Statement Of Income Or Comprehensive Income Extensible Enumeration GainOnBusinessInterruptionInsuranceRecoveryStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherOperatingIncomeExpenseNet
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.sabrahealth.com/20231231#AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.sabrahealth.com/20231231#AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet
CY2023Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2023Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#LineOfCredit http://fasb.org/us-gaap/2023#LoansPayableToBank
CY2022Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://www.sabrahealth.com/20231231#AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet
CY2022Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#LineOfCredit http://fasb.org/us-gaap/2023#LoansPayableToBank
CY2023Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://www.sabrahealth.com/20231231#AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-34950
CY2023	dei	Entity Registrant Name EntityRegistrantName	SABRA HEALTH CARE REIT, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-2560479
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1781 Flight Way
CY2023	dei	Trading Symbol TradingSymbol	SBRA
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	2700000000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	231476751	shares
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	238
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2023	dei	Auditor Location AuditorLocation	Irvine, California
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	1021086000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	913345000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4617261000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4959343000	usd
CY2023Q4	sbra	Financing Receivable And Other Investments Net FinancingReceivableAndOtherInvestmentsNet	420624000	usd
CY2022Q4	sbra	Financing Receivable And Other Investments Net FinancingReceivableAndOtherInvestmentsNet	411396000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	136843000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	134962000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41285000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49308000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5434000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	4624000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30897000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	40131000	usd
CY2023Q4	sbra	Accounts Receivable Prepaid Expenses Deferred Financing Costs And Other Assets Net AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet	133806000	usd
CY2022Q4	sbra	Accounts Receivable Prepaid Expenses Deferred Financing Costs And Other Assets Net AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet	147908000	usd
CY2023Q4	us-gaap	Assets Assets	5386150000	usd
CY2022Q4	us-gaap	Assets Assets	5747672000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	47301000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	49232000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	94429000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	196982000	usd
CY2023Q4	us-gaap	Loans Payable To Bank LoansPayableToBank	537120000	usd
CY2022Q4	us-gaap	Loans Payable To Bank LoansPayableToBank	526129000	usd
CY2023Q4	us-gaap	Unsecured Debt UnsecuredDebt	1735253000	usd
CY2022Q4	us-gaap	Unsecured Debt UnsecuredDebt	1734431000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	136981000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	142259000	usd
CY2023Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	32532000	usd
CY2022Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	42244000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2583616000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2691277000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	231266020	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	231266020	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	231009295	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	231009295	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2313000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2310000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4494755000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4486967000	usd
CY2023Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	1718279000	usd
CY2022Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	1451945000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	23745000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	19063000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2802534000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3056395000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5386150000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5747672000	usd
CY2023	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	376266000	usd
CY2022	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	400586000	usd
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	396716000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	236153000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	186672000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	155512000	usd
CY2023	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	35095000	usd
CY2022	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	37553000	usd
CY2021	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	17317000	usd
CY2023	us-gaap	Revenues Revenues	647514000	usd
CY2022	us-gaap	Revenues Revenues	624811000	usd
CY2021	us-gaap	Revenues Revenues	569545000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	183087000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	187782000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	178991000	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	112964000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	105471000	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	98632000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	47472000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	39574000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34669000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3935000	usd
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2598000	usd
CY2023	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-76625000	usd
CY2022	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-12011000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-75568000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-13519000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-21948000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	18655000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	21669000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	80670000	usd
CY2023	sbra	Income Loss From Equity Method Investments And Other Than Temporary Impairment IncomeLossFromEquityMethodInvestmentsAndOtherThanTemporaryImpairment	-2897000	usd
CY2022	sbra	Income Loss From Equity Method Investments And Other Than Temporary Impairment IncomeLossFromEquityMethodInvestmentsAndOtherThanTemporaryImpairment	-98032000	usd
CY2021	sbra	Income Loss From Equity Method Investments And Other Than Temporary Impairment IncomeLossFromEquityMethodInvestmentsAndOtherThanTemporaryImpairment	-192081000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2002000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1242000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1845000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	13756000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-77605000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-113256000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	231203391	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	230947895	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	219073027	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	232792778	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	230947895	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	219073027	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	13756000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-77605000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-113256000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-205000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3141000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-142000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	4887000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	25943000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	30032000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4682000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	29084000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	29890000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	18438000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-48521000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-83366000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-17000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-100000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	0	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	3409228000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-113256000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10748000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	308673000	usd
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.20
CY2021	us-gaap	Dividends Common Stock DividendsCommonStock	265753000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3379530000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-77605000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	29084000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9433000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-4911000	usd
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.20
CY2022	us-gaap	Dividends Common Stock DividendsCommonStock	279136000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	13756000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-77605000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-113256000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	183087000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	187782000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	178991000	usd
CY2023	sbra	Non Cash Rental And Related Revenues Adjustments NonCashRentalAndRelatedRevenuesAdjustments	-8699000	usd
CY2022	sbra	Non Cash Rental And Related Revenues Adjustments NonCashRentalAndRelatedRevenuesAdjustments	2183000	usd
CY2021	sbra	Non Cash Rental And Related Revenues Adjustments NonCashRentalAndRelatedRevenuesAdjustments	25823000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	372000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2285000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1988000	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	12265000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	11094000	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8368000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	7917000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	7453000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	7914000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1541000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-411000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-34622000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	191000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	141000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3935000	usd
CY2023	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-76625000	usd
CY2022	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-12011000	usd
CY2021	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	12301000	usd
CY2023	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	14332000	usd
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	94042000	usd
CY2021	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	9499000	usd
CY2023	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	usd
CY2022	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	57778000	usd
CY2021	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	164126000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2897000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-40254000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-27955000	usd
CY2023	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	3469000	usd
CY2022	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	usd
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	usd
CY2023	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-3704000	usd
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	2167000	usd
CY2021	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	11078000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6443000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-8223000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8344000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-13250000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	14479000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	300571000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	315733000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	356390000	usd
CY2023	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	78530000	usd
CY2022	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	92204000	usd
CY2021	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	99448000	usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	11418000	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	23812000	usd
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	290000000	usd
CY2023	sbra	Payments For Preferred Equity Investments PaymentsForPreferredEquityInvestments	11023000	usd
CY2022	sbra	Payments For Preferred Equity Investments PaymentsForPreferredEquityInvestments	8021000	usd
CY2021	sbra	Payments For Preferred Equity Investments PaymentsForPreferredEquityInvestments	9061000	usd
CY2023	us-gaap	Payments To Acquire Furniture And Fixtures PaymentsToAcquireFurnitureAndFixtures	84855000	usd
CY2022	us-gaap	Payments To Acquire Furniture And Fixtures PaymentsToAcquireFurnitureAndFixtures	54473000	usd
CY2021	us-gaap	Payments To Acquire Furniture And Fixtures PaymentsToAcquireFurnitureAndFixtures	42651000	usd
CY2023	sbra	Payments For Escrow Deposits For Potential Investments PaymentsForEscrowDepositsForPotentialInvestments	0	usd
CY2022	sbra	Payments For Escrow Deposits For Potential Investments PaymentsForEscrowDepositsForPotentialInvestments	780000	usd
CY2021	sbra	Payments For Escrow Deposits For Potential Investments PaymentsForEscrowDepositsForPotentialInvestments	0	usd
CY2023	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	9274000	usd
CY2022	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	5272000	usd
CY2021	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	2949000	usd
CY2023	sbra	Repayments Of Preferred Equity Investments RepaymentsOfPreferredEquityInvestments	-5460000	usd
CY2022	sbra	Repayments Of Preferred Equity Investments RepaymentsOfPreferredEquityInvestments	-5376000	usd
CY2021	sbra	Repayments Of Preferred Equity Investments RepaymentsOfPreferredEquityInvestments	-1292000	usd
CY2023	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	5235000	usd
CY2022	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	142910000	usd
CY2021	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	0	usd
CY2023	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets	247622000	usd
CY2022	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets	87304000	usd
CY2021	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets	100723000	usd
CY2023	us-gaap	Proceeds From Deposits On Real Estate Sales ProceedsFromDepositsOnRealEstateSales	0	usd
CY2022	us-gaap	Proceeds From Deposits On Real Estate Sales ProceedsFromDepositsOnRealEstateSales	8000000	usd
CY2021	us-gaap	Proceeds From Deposits On Real Estate Sales ProceedsFromDepositsOnRealEstateSales	0	usd
CY2023	us-gaap	Proceeds From Lease Payment Sales Type And Direct Financing Leases Investing Activity ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity	25490000	usd
CY2022	us-gaap	Proceeds From Lease Payment Sales Type And Direct Financing Leases Investing Activity ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity	0	usd
CY2021	us-gaap	Proceeds From Lease Payment Sales Type And Direct Financing Leases Investing Activity ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity	0	usd
CY2023	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	5801000	usd
CY2022	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	usd
CY2021	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	usd
CY2023	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	544000	usd
CY2022	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	usd
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	103130000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-216248000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-336196000	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-104338000	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	204046000	usd
CY2021	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	12188000	usd
CY2022	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	791520000	usd
CY2023	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	0	usd
CY2022	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	0	usd
CY2021	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	300000000	usd
CY2023	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	0	usd
CY2022	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	63750000	usd
CY2021	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	455000000	usd
CY2023	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1979000	usd
CY2022	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	17516000	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	18142000	usd
CY2023	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	30196000	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	2500000	usd
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2022	sbra	Proceeds Payments From Issuance Of Stock Net Of Taxes Paid On Behalf Of Employees ProceedsPaymentsFromIssuanceOfStockNetOfTaxesPaidOnBehalfOfEmployees	-4810000	usd
CY2021	sbra	Proceeds Payments From Issuance Of Stock Net Of Taxes Paid On Behalf Of Employees ProceedsPaymentsFromIssuanceOfStockNetOfTaxesPaidOnBehalfOfEmployees	308713000	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	277157000	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	262919000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-410300000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-161707000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	30140000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-6599000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-62222000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	50334000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-614000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	268000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53932000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115886000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	65523000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46719000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53932000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115886000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	102409000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	97723000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	85464000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	1670000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	1657000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	1839000	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	4644000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	14311000	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	0	usd
CY2022Q4	sbra	Real Estate Investments Joint Ventures Number RealEstateInvestmentsJointVenturesNumber	0	investment
CY2023Q4	sbra	Real Estate Investments Joint Ventures Number RealEstateInvestmentsJointVenturesNumber	0	investment
CY2023	us-gaap	Use Of Estimates UseOfEstimates	The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.
CY2023	us-gaap	Revenue Recognition Leases RevenueRecognitionLeases	<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes rental revenue from tenants, including rental abatements, lease incentives and contractual fixed increases attributable to operating leases, on a straight-line basis over the term of the related leases when it is probable that substantially all rents over the life of a lease are collectible. Certain of the Company’s leases provide for contingent rents equal to a percentage of the facility’s revenue in excess of specified base amounts or other thresholds. Such revenue is recognized when actual results reported by the tenant, or estimates of tenant results, exceed the applicable base amount or other threshold.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses the collectability of rents on a lease-by-lease basis, and in doing so, considers such things as historical bad debts, tenant creditworthiness, current economic trends, facility operating performance, lease structure, credit enhancements (including guarantees), current developments relevant to a tenant’s business specifically and to its business category generally, and changes in tenants’ payment patterns. The Company’s assessment includes an estimation of a tenant’s ability to fulfill all of its rental obligations over the remaining lease term. In addition, with respect to tenants in bankruptcy, management makes estimates of the expected recovery of pre-petition and post-petition claims in assessing the estimated collectability of the related receivable. If at any time the Company cannot determine that it is probable that substantially all rents over the life of a lease are collectible, rental revenue will be recognized only to the extent of payments received, and all receivables associated with the lease will be written off irrespective of amounts expected to be collectible. Any recoveries of these amounts will be recorded in future periods upon receipt of payment. Write-offs of receivables and any recoveries of previously written-off receivables are recorded as adjustments to rental revenue.</span></div>Revenue from resident fees and services is recorded monthly as services are provided and includes resident room and care charges, ancillary services charges and other resident charges.
CY2022Q4	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	0	usd
CY2023Q4	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	0	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5400000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	4600000	usd
CY2023Q4	sbra	Accrued Obligations Associated With Restricted Cash AccruedObligationsAssociatedWithRestrictedCash	1400000	usd
CY2022Q4	sbra	Accrued Obligations Associated With Restricted Cash AccruedObligationsAssociatedWithRestrictedCash	3900000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11600000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8500000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	12500000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9200000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	1400000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	1200000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	1200000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P17Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1310000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1802000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1324000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1347000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1330000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	18104000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	25217000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	12729000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	12488000	usd
CY2021	us-gaap	Disposal Group Not Discontinued Operation Loss Gain On Write Down DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown	9500000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	5638347000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	1021086000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4617261000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	5872688000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	913345000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4959343000	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	4843258000	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	5034470000	usd
CY2023Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	238185000	usd
CY2022Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	262644000	usd
CY2023Q4	us-gaap	Land Improvements LandImprovements	10306000	usd
CY2022Q4	us-gaap	Land Improvements LandImprovements	7085000	usd
CY2023Q4	us-gaap	Land Land	546598000	usd
CY2022Q4	us-gaap	Land Land	568489000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	5638347000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	5872688000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	1021086000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	913345000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4617261000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4959343000	usd
CY2023Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	16400000	usd
CY2022Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	13000000	usd
CY2023Q4	sbra	Letters Of Credit Deposits LettersOfCreditDeposits	56000000	usd
CY2022Q4	sbra	Letters Of Credit Deposits LettersOfCreditDeposits	57000000	usd
CY2023Q4	sbra	Property Taxes Insurance And Tenant Improvement Deposit Liability PropertyTaxesInsuranceAndTenantImprovementDepositLiability	12400000	usd
CY2022Q4	sbra	Property Taxes Insurance And Tenant Improvement Deposit Liability PropertyTaxesInsuranceAndTenantImprovementDepositLiability	13300000	usd
CY2023	us-gaap	Variable Lease Income VariableLeaseIncome	15300000	usd
CY2022	us-gaap	Variable Lease Income VariableLeaseIncome	17700000	usd
CY2021	us-gaap	Variable Lease Income VariableLeaseIncome	18000000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	377721000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	372911000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	357434000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	334489000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	310963000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	1289067000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	3042585000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	27000000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	136843000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	134962000	usd
CY2023	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	14300000	usd
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	94000000	usd
CY2021	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	9500000	usd
CY2023	sbra	Disposal Group Including Discontinued Operations Number Of Properties DisposalGroupIncludingDiscontinuedOperationsNumberOfProperties	28	facility
CY2022	sbra	Disposal Group Including Discontinued Operations Number Of Properties DisposalGroupIncludingDiscontinuedOperationsNumberOfProperties	18	facility
CY2021	sbra	Disposal Group Including Discontinued Operations Number Of Properties DisposalGroupIncludingDiscontinuedOperationsNumberOfProperties	16	facility
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Consideration DisposalGroupIncludingDiscontinuedOperationConsideration	255600000	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Consideration DisposalGroupIncludingDiscontinuedOperationConsideration	87300000	usd
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Consideration DisposalGroupIncludingDiscontinuedOperationConsideration	103400000	usd
CY2023Q4	sbra	Disposal Group Including Discontinued Operation Assets And Liabilities Net DisposalGroupIncludingDiscontinuedOperationAssetsAndLiabilitiesNet	332200000	usd
CY2022Q4	sbra	Disposal Group Including Discontinued Operation Assets And Liabilities Net DisposalGroupIncludingDiscontinuedOperationAssetsAndLiabilitiesNet	99300000	usd
CY2021Q4	sbra	Disposal Group Including Discontinued Operation Assets And Liabilities Net DisposalGroupIncludingDiscontinuedOperationAssetsAndLiabilitiesNet	92100000	usd
CY2023	sbra	Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List Not Disclosed Flag DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag	Net (loss) gain on sale
CY2023	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-76600000	usd
CY2022	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-12000000.0	usd
CY2021	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	11300000	usd
CY2023	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-80900000	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-94800000	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	21500000	usd
CY2023	us-gaap	Disposal Group Not Discontinued Operation Loss Gain On Write Down DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown	7100000	usd
CY2022	us-gaap	Disposal Group Not Discontinued Operation Loss Gain On Write Down DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown	94000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	67550000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	86193000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	36653000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	46062000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30897000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	40131000	usd
CY2023Q4	us-gaap	Below Market Lease Gross BelowMarketLeaseGross	68573000	usd
CY2022Q4	us-gaap	Below Market Lease Gross BelowMarketLeaseGross	80208000	usd
CY2023Q4	us-gaap	Below Market Lease Accumulated Amortization BelowMarketLeaseAccumulatedAmortization	36041000	usd
CY2022Q4	us-gaap	Below Market Lease Accumulated Amortization BelowMarketLeaseAccumulatedAmortization	37964000	usd
CY2023Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	32532000	usd
CY2022Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	42244000	usd
CY2023	us-gaap	Amortization Of Above And Below Market Leases AmortizationOfAboveAndBelowMarketLeases	-5821000	usd
CY2022	us-gaap	Amortization Of Above And Below Market Leases AmortizationOfAboveAndBelowMarketLeases	-6624000	usd
CY2021	us-gaap	Amortization Of Above And Below Market Leases AmortizationOfAboveAndBelowMarketLeases	13512000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11616000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17591000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8694000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5523000	usd
CY2023Q4	us-gaap	Below Market Lease Amortization Income Next Twelve Months BelowMarketLeaseAmortizationIncomeNextTwelveMonths	5690000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4612000	usd
CY2023Q4	us-gaap	Below Market Lease Amortization Income Year Two BelowMarketLeaseAmortizationIncomeYearTwo	5139000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4411000	usd
CY2023Q4	us-gaap	Below Market Lease Amortization Income Year Three BelowMarketLeaseAmortizationIncomeYearThree	4884000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3115000	usd
CY2023Q4	us-gaap	Below Market Lease Amortization Income Year Four BelowMarketLeaseAmortizationIncomeYearFour	4442000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2662000	usd
CY2023Q4	us-gaap	Below Market Lease Amortization Income Year Five BelowMarketLeaseAmortizationIncomeYearFive	4296000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	10574000	usd
CY2023Q4	us-gaap	Below Market Lease Amortization Income After Year Five BelowMarketLeaseAmortizationIncomeAfterYearFive	8081000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30897000	usd
CY2023Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	32532000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P8Y9M18D
CY2023Q4	sbra	Below Market Lease Remaining Amortization Period BelowMarketLeaseRemainingAmortizationPeriod	P6Y6M
CY2023Q4	sbra	Financing Receivable Number Of Loans FinancingReceivableNumberOfLoans	14	loan
CY2023Q4	sbra	Financing Receivable Principal Amount FinancingReceivablePrincipalAmount	372873000	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	369440000	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	366936000	usd
CY2023Q4	sbra	Financing Receivable Fixed Interest Rate FinancingReceivableFixedInterestRate	0.077
CY2023Q4	sbra	Financing Receivable Effective Interest Rate FinancingReceivableEffectiveInterestRate	0.076
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	6665000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	6611000	usd
CY2023Q4	sbra	Financing Receivable Principal Amount FinancingReceivablePrincipalAmount	372873000	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	362775000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	360325000	usd
CY2023Q4	sbra	Preferred Equity Investments Number PreferredEquityInvestmentsNumber	5	preferredequityinvestment
CY2023Q4	sbra	Preferred Equity Investment Face Value PreferredEquityInvestmentFaceValue	57681000	usd
CY2023Q4	sbra	Preferred Equity Investment Carrying Amount PreferredEquityInvestmentCarryingAmount	57849000	usd
CY2022Q4	sbra	Preferred Equity Investment Carrying Amount PreferredEquityInvestmentCarryingAmount	51071000	usd
CY2023Q4	sbra	Preferred Equity Investment Weighted Average Contractual Rate PreferredEquityInvestmentWeightedAverageContractualRate	0.110
CY2023Q4	sbra	Preferred Equity Investment Weighted Average Effective Rate PreferredEquityInvestmentWeightedAverageEffectiveRate	0.110
CY2023Q4	sbra	Number Of Investments NumberOfInvestments	19	investment
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	430554000	usd
CY2023Q4	sbra	Financing Receivable And Other Investments Net FinancingReceivableAndOtherInvestmentsNet	420624000	usd
CY2022Q4	sbra	Financing Receivable And Other Investments Net FinancingReceivableAndOtherInvestmentsNet	411396000	usd
CY2023Q4	sbra	Investments Weighted Average Contractual Rate InvestmentsWeightedAverageContractualRate	0.081
CY2023Q4	sbra	Investments Weighted Average Effective Rate InvestmentsWeightedAverageEffectiveRate	0.081
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	6611000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	6344000	usd
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	2458000	usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	192000	usd
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	267000	usd
CY2021	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	3886000	usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	138000	usd
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	0	usd
CY2021	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	0	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	6665000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	6611000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	6344000	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	113000000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	105500000	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	98600000	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	12300000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	11100000	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8400000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	16500000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	18200000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2033000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2089000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	502147000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	196635000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	545456000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1187402000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2435762000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	4258000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	17401000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	2414103000	usd
CY2023	sbra	Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax	6531000	usd
CY2022	sbra	Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax	39869000	usd
CY2021	sbra	Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax	16798000	usd
CY2023	sbra	Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossReclassificationBeforeTax	8332000	usd
CY2022	sbra	Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossReclassificationBeforeTax	-4179000	usd
CY2021	sbra	Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossReclassificationBeforeTax	-12774000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	18918000	usd
CY2023Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	18918000	usd
CY2023Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	0	usd
CY2023Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	18918000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0	usd
CY2023Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	0	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	21477000	usd
CY2022Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	21477000	usd
CY2022Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	0	usd
CY2022Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	21477000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0	usd
CY2022Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2022Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	usd
CY2022Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	0	usd
CY2023Q4	sbra	Financing Receivable Principal Amount FinancingReceivablePrincipalAmount	372873000	usd
CY2022Q4	sbra	Financing Receivable Principal Amount FinancingReceivablePrincipalAmount	370364000	usd
CY2023Q4	sbra	Preferred Equity Investment Face Value PreferredEquityInvestmentFaceValue	57681000	usd
CY2022Q4	sbra	Preferred Equity Investment Face Value PreferredEquityInvestmentFaceValue	50902000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1800000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3300000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2100000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	9100000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	5700000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	15900000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	7900000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	7500000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	7900000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	25700000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y8M12D
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.04
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	300000	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	300000	usd
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	300000	usd
CY2023	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	2002000	usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	1234000	usd
CY2021	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	2263000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	8000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-418000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2002000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1242000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1845000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2021	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2022	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	13756000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-77605000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-113256000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	231203391	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	230947895	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	219073027	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1589387	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	232792778	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	230947895	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	219073027	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52
CY2023Q4	srt	Real Estate And Accumulated Depreciation Amount Of Encumbrances RealEstateAndAccumulatedDepreciationAmountOfEncumbrances	48143000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Land RealEstateAndAccumulatedDepreciationInitialCostOfLand	546940000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Buildings And Improvements RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements	4831080000	usd
CY2023Q4	sbra	Real Estate And Accumulated Depreciation Initial Cost RealEstateAndAccumulatedDepreciationInitialCost	5378020000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Carrying Costs RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionCarryingCosts	234491000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Land RealEstateAndAccumulatedDepreciationCarryingAmountOfLand	546598000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Buildings And Improvements RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements	5091749000	usd
CY2023Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	5638347000	usd
CY2023Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	1021086000	usd
CY2023Q4	sbra	Real Estate And Accumulated Depreciation Initial Cost Tax Basis RealEstateAndAccumulatedDepreciationInitialCostTaxBasis	4700000000	usd
CY2022Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	5872688000	usd
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	5994208000	usd
CY2020Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	5966695000	usd
CY2023	us-gaap	Real Estate Other Acquisitions RealEstateOtherAcquisitions	86626000	usd
CY2022	us-gaap	Real Estate Other Acquisitions RealEstateOtherAcquisitions	101413000	usd
CY2021	us-gaap	Real Estate Other Acquisitions RealEstateOtherAcquisitions	96157000	usd
CY2023	us-gaap	Real Estate Improvements RealEstateImprovements	86073000	usd
CY2022	us-gaap	Real Estate Improvements RealEstateImprovements	65111000	usd
CY2021	us-gaap	Real Estate Improvements RealEstateImprovements	47319000	usd
CY2023	sbra	Sec Schedule Iii Real Estate Impairments SECScheduleIIIRealEstateImpairments	18853000	usd
CY2022	sbra	Sec Schedule Iii Real Estate Impairments SECScheduleIIIRealEstateImpairments	160550000	usd
CY2021	sbra	Sec Schedule Iii Real Estate Impairments SECScheduleIIIRealEstateImpairments	11063000	usd
CY2023	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	379272000	usd
CY2022	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	110901000	usd
CY2021	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	102575000	usd
CY2023	sbra	Sec Schedule Iii Real Estate Foreign Currency Translation SECScheduleIIIRealEstateForeignCurrencyTranslation	3394000	usd
CY2022	sbra	Sec Schedule Iii Real Estate Foreign Currency Translation SECScheduleIIIRealEstateForeignCurrencyTranslation	-10247000	usd
CY2021	sbra	Sec Schedule Iii Real Estate Foreign Currency Translation SECScheduleIIIRealEstateForeignCurrencyTranslation	524000	usd
CY2023	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	12309000	usd
CY2022	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	6346000	usd
CY2021	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	2849000	usd
CY2023Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	5638347000	usd
CY2022Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	5872688000	usd
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	5994208000	usd
CY2022Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	913345000	usd
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	831324000	usd
CY2020Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	681657000	usd
CY2023	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	171278000	usd
CY2022	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	170159000	usd
CY2021	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	170264000	usd
CY2023	sbra	Sec Schedule Iii Real Estate Accumulated Depreciation Impairment SECScheduleIIIRealEstateAccumulatedDepreciationImpairment	4432000	usd
CY2022	sbra	Sec Schedule Iii Real Estate Accumulated Depreciation Impairment SECScheduleIIIRealEstateAccumulatedDepreciationImpairment	66603000	usd
CY2021	sbra	Sec Schedule Iii Real Estate Accumulated Depreciation Impairment SECScheduleIIIRealEstateAccumulatedDepreciationImpairment	1666000	usd
CY2023	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	49585000	usd
CY2022	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	13217000	usd
CY2021	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	16097000	usd
CY2023	sbra	Sec Schedule Iii Real Estate Accumulated Depreciation Foreign Currency Translation SECScheduleIIIRealEstateAccumulatedDepreciationForeignCurrencyTranslation	747000	usd
CY2022	sbra	Sec Schedule Iii Real Estate Accumulated Depreciation Foreign Currency Translation SECScheduleIIIRealEstateAccumulatedDepreciationForeignCurrencyTranslation	-1972000	usd
CY2021	sbra	Sec Schedule Iii Real Estate Accumulated Depreciation Foreign Currency Translation SECScheduleIIIRealEstateAccumulatedDepreciationForeignCurrencyTranslation	15000	usd
CY2023	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	10267000	usd
CY2022	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	6346000	usd
CY2021	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	2849000	usd
CY2023Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	1021086000	usd
CY2022Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	913345000	usd
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	831324000	usd
CY2023Q4	srt	Mortgage Loans On Real Estate Federal Income Tax Basis1 MortgageLoansOnRealEstateFederalIncomeTaxBasis1	321200000	usd
CY2022Q4	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	319000000	usd
CY2021Q4	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	312343000	usd
CY2020Q4	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	22343000	usd
CY2023	us-gaap	Mortgage Loans On Real Estate Period Increase Decrease MortgageLoansOnRealEstatePeriodIncreaseDecrease	0	usd
CY2022	us-gaap	Mortgage Loans On Real Estate Period Increase Decrease MortgageLoansOnRealEstatePeriodIncreaseDecrease	10000000	usd
CY2021	us-gaap	Mortgage Loans On Real Estate Period Increase Decrease MortgageLoansOnRealEstatePeriodIncreaseDecrease	0	usd
CY2023	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	0	usd
CY2022	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	0	usd
CY2021	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	290000000	usd
CY2023	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	0	usd
CY2022	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	3343000	usd
CY2021	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	0	usd
CY2023Q4	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	319000000	usd
CY2022Q4	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	319000000	usd
CY2021Q4	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	312343000	usd

Files In Submission

Name	View Source	Status
0001492298-24-000008-index-headers.html	Edgar Link	pending
0001492298-24-000008-index.html	Edgar Link	pending
0001492298-24-000008.txt	Edgar Link	pending
0001492298-24-000008-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
report.css	Edgar Link	pending
sbra-20231231.htm	Edgar Link	pending
sbra-20231231.xsd	Edgar Link	pending
sbra-20231231_g1.jpg	Edgar Link	pending
sbraex1092023q4.htm	Edgar Link	pending
sbraex2112023q4.htm	Edgar Link	pending
sbraex2312023q4.htm	Edgar Link	pending
sbraex3112023q4.htm	Edgar Link	pending
sbraex3122023q4.htm	Edgar Link	pending
sbraex3212023q4.htm	Edgar Link	pending
sbraex3222023q4.htm	Edgar Link	pending
sbraex9712023q4.htm	Edgar Link	pending
Show.js	Edgar Link	pending
sbra-20231231_def.xml	Edgar Link	unprocessable
sbra-20231231_lab.xml	Edgar Link	unprocessable
sbra-20231231_pre.xml	Edgar Link	unprocessable
sbra-20231231_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
sbra-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SBRA
Sabra Health Care REIT, Inc. Stock $sbra

2024 Q1 Form 10-K Financial Statement

#000149229824000008 Filed on February 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBRA Sabra Health Care REIT, Inc. Stock $sbra

2024 Q1 Form 10-K Financial Statement

#000149229824000008 Filed on February 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBRA
Sabra Health Care REIT, Inc. Stock $sbra